FDA-cleared profile

HeartFocus (V.1.1.1)

Deski · Ultrasound · FDA-cleared (510(k))

Authorized purpose: HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.

Clinical role
Acquisition guidance and image-quality/recording assistance
Images and patients
Ultrasound · Heart/Cardiovascular
Key limitation
Keep in mind: Adult acquisition aid requiring trained users and qualified interpretation. Clinical-study image quality varied by view, particularly subcostal IVC. PCCP allows specified compatibility changes after validation; it does not establish that every current probe/OS was tested in the initial v1.1.1 study.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Heart/Cardiovascular Input: Live adult 2D-TTE ultrasound stream; initial compatibility lists Clarius PAHD3 wireless, PAHD, PAL and Clarius Ultrasound Scanner Software. Views: PLAX, PSAX-AV/MV/PM, A4C/A5C/A2C/A3C, SC-4C and SC-IVC.
  • Who uses it?Intended users: Medical professionals trained in ultrasound basics and HeartFocus use, including trained nurses, physicians and sonographers
  • What does the software produce?Output: Probe-position guidance cues, color-coded diagnostic-quality feedback, Auto Record, Best-Effort Record and recorded-clip quality information; acquired exams are available for clinician review and transfer.
  • What is its most important limitation?Key limitation: Adult acquisition aid requiring trained users and qualified interpretation. Clinical-study image quality varied by view, particularly subcostal IVC. PCCP allows specified compatibility changes after validation; it does not establish that every current probe/OS was tested in the initial v1.1.1 study.

Clinical takeaway. Clinical role: HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.

Evidence takeaway. Evidence from the reviewed source record: The initial Clarius/v1.1.1 evidence supports trained-user image acquisition with expert interpretation. Current Butterfly family features and commercial terms cannot be used as original-study results.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.
  • Exact FDA submission
  • Checked 2026-09-05
Workflow role
Acquisition guidance and image-quality/recording assistance
  • Exact FDA submission
  • Checked 2026-09-05
Required input
Live adult 2D-TTE ultrasound stream; initial compatibility lists Clarius PAHD3 wireless, PAHD, PAL and Clarius Ultrasound Scanner Software. Views: PLAX, PSAX-AV/MV/PM, A4C/A5C/A2C/A3C, SC-4C and SC-IVC.
  • Exact FDA submission
  • Checked 2026-09-05
Output and clinician action
Probe-position guidance cues, color-coded diagnostic-quality feedback, Auto Record, Best-Effort Record and recorded-clip quality information; acquired exams are available for clinician review and transfer.
  • Exact FDA submission
  • Checked 2026-09-05
Care setting
Adult patients requiring cardiac ultrasound; prospective validation included clinically indicated exams at French and US centers
  • Exact FDA submission
  • Checked 2026-09-05
Intended users
Medical professionals trained in ultrasound basics and HeartFocus use, including trained nurses, physicians and sonographers
  • Exact FDA submission
  • Checked 2026-09-05
Limitations
Adult acquisition aid requiring trained users and qualified interpretation. Clinical-study image quality varied by view, particularly subcostal IVC. PCCP allows specified compatibility changes after validation; it does not establish that every current probe/OS was tested in the initial v1.1.1 study.
  • Exact FDA submission
  • Checked 2026-09-05
Evidence summary
The initial Clarius/v1.1.1 evidence supports trained-user image acquisition with expert interpretation. Current Butterfly family features and commercial terms cannot be used as original-study results.
  • Exact FDA submission
  • Checked 2026-09-05

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The initial Clarius/v1.1.1 evidence supports trained-user image acquisition with expert interpretation. Current Butterfly family features and commercial terms cannot be used as original-study results.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

A single disease-detection sensitivity is not established by the reviewed acquisition-quality studies.

Reported specificity
93.9%
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-13

Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.

Best-Effort Record diagnostic-quality clip yield

93.9 percent

  • EndpointProportion of clips saved with Best-Effort Record judged of diagnostic image quality in the prospective acquisition study
  • Population240 adults aged at least 22 at one French and one US center; eight nurse operators, five blinded cardiologist assessors; recorded clips graded using ACEP scale
  • Tested versionHeartFocus v1.1.1 with Clarius in K242807 clinical study

K242807 HeartFocus prospective acquisition study

  • DesignManufacturer prospective multicenter paired acquisition study; trained novice nurses compared with experts on the same ultrasound system, five blinded cardiologist reviewers
  • Population240 clinically indicated echocardiography patients aged at least 22; 120 France and 120 US
  • Scopeexact submission
  • Tested versionHeartFocus v1.1.1 with Clarius
  • Samplen=240
  • Sites2
  • IndependenceSponsor or vendor study

K242807

Eight nurses acquired ten views; four primary endpoints assessed examination suitability for visual LV size/function, RV size and nontrivial effusion evaluation. Secondary quality outcomes were descriptive and varied by view; not an autonomous diagnosis study.

K242807 HeartFocus algorithm performance testing

  • DesignManufacturer standalone evaluation of view classification, guidance cues and recording, with expert annotations
  • Population290 patients and 361,104 images in the test pool, with feature-specific subsets and additional retrospective evaluation of trial data
  • Scopeexact submission
  • Tested versionHeartFocus v1.1.1
  • Samplen=290
  • IndependenceSponsor or vendor study

K242807

The 290-patient algorithm pool and 240-patient clinical study are distinct denominators, not a single combined cohort.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Pricing is recorded, but no exact-product procurement price with a stated offer scope is published in the reviewed sources.

Public pricing
The current HeartFocus family pricing page displays $695 per license/year/probe or $1,800 per license/three years/probe for up to five licenses, with unlimited users; enterprise six-plus licenses require a quote.
  • Product family
  • Checked 2026-09-05

Current family offer, not an exact v1.1.1/Clarius quote. The page shows a dollar sign but no ISO currency; no normalized price observation is emitted. Hardware, tax and local contract inclusions require confirmation.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Live adult 2D-TTE ultrasound stream; initial compatibility lists Clarius PAHD3 wireless, PAHD, PAL and Clarius Ultrasound Scanner Software. Views: PLAX, PSAX-AV/MV/PM, A4C/A5C/A2C/A3C, SC-4C and SC-IVC.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-05 · FDA 510(k) K242807: HeartFocus v1.1.1

  2. Routing

    Source context, not route validation: Connects to a compatible ultrasound system's image stream; collected exams can be transferred using DICOM protocols.

    Scope: Exact FDA submission. Specific PACS/RIS/EHR configuration and later ultrasound integrations need confirmation.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-05 · FDA 510(k) K242807: HeartFocus v1.1.1

  3. AI processing

    Source context, not route validation: The FDA summary describes an offline application with medical data stored locally on the tablet and no data transfer to a DESKi-controlled server for its functions.

    Scope: Exact FDA submission. Corrects the baseline's nonspecific Hybrid label using the exact summary; current device configuration remains separately scoped.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-05 · FDA 510(k) K242807: HeartFocus v1.1.1

  4. Returned objects

    Source context, not route validation: Probe-position guidance cues, color-coded diagnostic-quality feedback, Auto Record, Best-Effort Record and recorded-clip quality information; acquired exams are available for clinician review and transfer.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-05 · FDA 510(k) K242807: HeartFocus v1.1.1

  5. Viewer/worklist/report

    Unresolved route: Probe-position guidance cues, color-coded diagnostic-quality feedback, Auto Record, Best-Effort Record and recorded-clip quality information; acquired exams are available for clinician review and transfer.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-05 · FDA 510(k) K242807: HeartFocus v1.1.1

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The FDA summary describes an offline application with medical data stored locally on the tablet and no data transfer to a DESKi-controlled server for its functions.
  • Exact FDA submission
  • Checked 2026-09-05

Corrects the baseline's nonspecific Hybrid label using the exact summary; current device configuration remains separately scoped.

Integration
Connects to a compatible ultrasound system's image stream; collected exams can be transferred using DICOM protocols.
  • Exact FDA submission
  • Checked 2026-09-05

Specific PACS/RIS/EHR configuration and later ultrasound integrations need confirmation.

Security
DESKi's coordinated vulnerability disclosure policy, scoped to DESKi products and services, provides security researcher prerequisites (no patient-safety risk, written permission before testing, coordinated public disclosure timing), an encrypted reporting channel (security@deski.ai with a public PGP key), and handling expectations for vulnerability reports.
  • Vendor-wide
  • Checked 2026-10-27

Vendor CVD policy naming DESKi on the HeartFocus product site (heartfocus.ai), which uses the deski.ai contact domain. Exact-release scope is not established.

Training
Users require ultrasound-basics and HeartFocus training provided by DESKi or a trained medical professional using approved training material.
  • Exact FDA submission
  • Checked 2026-09-05

Exact local competency sign-off, onboarding duration and contractual support remain site/vendor matters.

Monitoring
DESKi's coordinated vulnerability disclosure policy, scoped to DESKi products and services, states acknowledgement of receipt within two business days, investigation and risk analysis of reported vulnerabilities, and a summary of findings provided to the submitter.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement, not an attestation. The policy names DESKi products and services generally and does not scope these commitments to any specific product release; exact-release scope is not established. This is an intake and response-handling commitment; it states no uptime, drift or continuous-monitoring claims.

Current family supported configuration

The current official FAQ describes Butterfly iQ+/iQ3 with supported iPad/iPhone devices, offline guidance, and DICOM PACS transfer.

product family · checked 2026-09-05

Current family documentation; the initial K242807 summary and clinical evidence describe Clarius. Verify installed release/probe linkage before use.

Clinician training

Ultrasound-basics and product training using approved materials are required.

exact submission · checked 2026-09-05
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K242807
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-04-04
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-05Last searched
21Fields reviewed
12Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

Stored DESKi-sponsored PROSPECTIVE EVALUATION OF HEARTFOCUS metadata screened. Live registry page exposed only an application shell, so trial details and exact release linkage were not established; no registry result promoted. Clinical-study abstraction is sourced to the FDA summary only. Stored PubMed array empty. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor pricing, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Deski HeartFocus reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

9 sources - 3 history items

Source ledger

  1. FDA 510(k) K242807: HeartFocus v1.1.1

    U.S. Food and Drug Administration - Accessed 2026-09-05

    Scope: identity, clinicalUse, modality, anatomy, implementationCapabilities, evidenceStudies, training

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. HeartFocus (V.1.1.1) model card (K242807)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. HeartFocus official FAQ: current product family

    DESKi / HeartFocus - Accessed 2026-09-05

    Scope: productFamily, implementationCapabilities

  8. HeartFocus current family pricing

    DESKi / HeartFocus - Accessed 2026-09-05

    Scope: pricing, currentCommercialContext

  9. DESKi: Coordinated Vulnerability Disclosure

    DESKi - Accessed 2026-10-27

    Scope: security

Research history

  1. K242807 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260780

HeartFocus

Deski

Authorized purpose: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2026-06-03
FDA-cleared K253535

Ligence Heart

Ligence Uab

Ligence Heart is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or sonographers for clinical decision making. Ligence Heart is indicated for use in adult patients. Ligence Heart has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g., tumors, thrombi). Limitations: Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. If no gender is present, female referenced guideline values will be used for conclusions. If Body Surface Area (BSA) is not present, indexed values cannot be provided. During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, or use of suboptimal settings (e.g., gain, contrast, depth) may lead to lower accuracy of the software. Ligence Heart has not been validated in patients with prosthetic or surgically altered cardiac valves, implantable intracardiac devices, or irregular (non-sinus) rhythm; these conditions may affect automated measurement accuracy.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2026-02-27
FDA-cleared K252235

PVAD IQ Software

Ultrasight, Ltd.

Authorized purpose: PVAD IQ supports qualified-physician clinical decision support by identifying the aortic annulus and PVAD inlet, calculating their mean distance, and identifying clips acceptable for this measurement.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2025-12-18

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history